This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Zecotek Signs Joint Collaboration Agreement With Intellectual Ventures

VANCOUVER, June 28, 2013 /PRNewswire/ - Zecotek Photonics Inc. (TSX-V: ZMS; OTCPK: ZMSPF, Frankfurt: W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that it has entered into a joint collaboration agreement with Intellectual Ventures (IV ®) of Bellevue, Washington. The two companies will collaborate on intellectual property strategy, including the sourcing, development, and monetization of new inventions related to photonics. IV is one of the largest owners of U.S. patents and works closely with inventors to develop and protect intellectual property.

"The agreement with Intellectual Ventures marks another important step for Zecotek in the effort to build and protect its valuable patent portfolio of over 50 patents," said Dr. A. Faouzi Zerrouk, Founder and CEO of Zecotek.  "The collaboration with Intellectual Ventures aims to enhance the innovation pipelines available to Zecotek, further strengthen our intellectual property portfolio, and align us with the world's leading specialty invention company."

"Intellectual Ventures is proud to collaborate with and offer consultation to Zecotek, a cutting-edge photonics technology company," said Chris Alliegro, Executive Vice President and Managing Director, Invention Development Fund at Intellectual Ventures. "The inventors at Zecotek are truly world-class, and through this collaboration we will create a strong portfolio of photonics related inventions and patents that bring further innovation to important products such as PET-MRI imaging systems used in medical, and industrial systems."

The agreement also provides Zecotek with the opportunity to license IP and technologies from the IV Invention Development Fund's own portfolio of photonics related inventions and patents created with its network of more than 4,000 inventors - including individual inventors and inventors from government labs, research institutions, corporations and universities. As part of the terms of the agreement, Intellectual Ventures will have the first right of refusal to purchase any inventions or patents Zecotek may choose to divest.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,872.85 -103.46 -0.58%
S&P 500 2,077.58 -8.66 -0.42%
NASDAQ 4,924.0940 -23.3470 -0.47%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs